These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 17493386)

  • 1. [Relationship between expression of decoy receptor 3 and apoptosis in hepatocellular carcinoma].
    Chen G; Luo DZ; Wang Y; Liao ZL; Zhang MY
    Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):113-7. PubMed ID: 17493386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of decoy receptor 3 in liver tissue microarrays.
    Chen G; Luo D
    Natl Med J India; 2008; 21(6):275-8. PubMed ID: 19691215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Overexpression and genomic amplification of decoy receptor 3 in hepatocellular carcinoma and significance thereof].
    Shen HW; Wu YL; Peng SY
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):744-7. PubMed ID: 12899749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of decoy receptor 3 in hepatocellular carcinoma and its association with resistance to Fas ligand-mediated apoptosis.
    Shen HW; Gao SL; Wu YL; Peng SY
    World J Gastroenterol; 2005 Oct; 11(38):5926-30. PubMed ID: 16273601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and clinical significance of TAp73alpha, p53, PCNA and apoptosis in hepatocellular carcinoma.
    Qin HX; Nan KJ; Yang G; Jing Z; Ruan ZP; Li CL; Xu R; Guo H; Sui CG; Wei YC
    World J Gastroenterol; 2005 May; 11(18):2709-13. PubMed ID: 15884108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promotive Effects of Dcr3 Gene on the Occurrence and Progression of Gastric Cancer and its Mechanism.
    Zheng XF; Miao LY; Li S; Wang YB
    Hepatogastroenterology; 2014 May; 61(131):880-4. PubMed ID: 26176090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of decoy receptor 3 in sera of hepatocellular carcinoma patients.
    Yang M; Chen G; Dang Y; Luo D
    Ups J Med Sci; 2010 Nov; 115(4):232-7. PubMed ID: 20977315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNFRSF6B neutralization antibody inhibits proliferation and induces apoptosis in hepatocellular carcinoma cell.
    Chen G; Rong M; Luo D
    Pathol Res Pract; 2010 Sep; 206(9):631-41. PubMed ID: 20591579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serine/arginine rich splicing factor 2 expression and clinic pathological features indicating a prognostic factor in human hepatocellular carcinoma patients.
    Wang P; Guo L; Li K; Ning S; Shi W; Liu Z; Chen Y
    Cancer Biomark; 2018 Feb; 21(3):681-687. PubMed ID: 29278882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].
    Liu Y; Chen X; Peng S; Fang H; Wu Y; Peng C; Shi L; Bai M; Xu B; Wang J; Deng G
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1553-6. PubMed ID: 12609066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association of cellular inhibitor of apoptosis protein-2 expression with clinical outcomes of hepatocellular carcinoma].
    Bi M; Yang D; Li X; Zhong K; Liu Y; Li G; Liao X; Liu X
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun; 32(7):1020-5, 1030. PubMed ID: 22820591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular apoptosis susceptibility protein and proliferation in human hepatocellular carcinoma.
    Shiraki K; Fujikawa K; Sugimoto K; Ito T; Yamanaka T; Suzuki M; Yoneda K; Sugimoto K; Takase K; Nakano T
    Int J Mol Med; 2006 Jul; 18(1):77-81. PubMed ID: 16786158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.
    Pan HW; Ou YH; Peng SY; Liu SH; Lai PL; Lee PH; Sheu JC; Chen CL; Hsu HC
    Cancer; 2003 Jul; 98(1):119-27. PubMed ID: 12833464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation of NY-ESO-1 gene and protein expression to metastasis and clinicopathologic features of hepatocellular carcinoma].
    Zhang WM; Xiao G; Xie D; Zhang M; Guo AL; Wen JM
    Ai Zheng; 2005 May; 24(5):622-6. PubMed ID: 15890110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of tissue factor in hepatocellular carcinoma genesis, invasion and metastasis.
    Zhou Q; Huang T; Wang YF; Zhou XB; Liang LJ; Peng BG
    Chin Med J (Engl); 2011 Nov; 124(22):3746-51. PubMed ID: 22340235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and significance of EGF mRNA and EGFR mRNA in hepatocellular carcinoma].
    Zhao YN; Cao J; Wu FX; Ou C; Yuan WP; Mo QG; Wei W; Li Y; Su JJ; Liang AM
    Ai Zheng; 2004 Jul; 23(7):762-6. PubMed ID: 15248908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma.
    Lin SY; Pan HW; Liu SH; Jeng YM; Hu FC; Peng SY; Lai PL; Hsu HC
    Clin Cancer Res; 2008 Aug; 14(15):4814-20. PubMed ID: 18676753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of miR-340 on hepatocellular carcinoma by targeting the DcR3 gene.
    Xie L; Chen Z; Liu H; Guan L; Wang Z; Li W
    Dig Liver Dis; 2018 Mar; 50(3):291-296. PubMed ID: 29311025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of matrix metalloproteinase-9 in predicting prognosis of hepatocellular carcinoma after liver transplantation.
    Nart D; Yaman B; Yilmaz F; Zeytunlu M; Karasu Z; Kiliç M
    Liver Transpl; 2010 May; 16(5):621-30. PubMed ID: 20440771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.